| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/19/2005 | CN1566054A Resveratrol oligo cattail compounds, its manufacturing process, pharmaceutical combination and uses thereof |
| 01/19/2005 | CN1565601A Application of sichuan lovage rhizome oil by supercritical CO2 extraction method in pharmacy |
| 01/19/2005 | CN1565596A Natural green medicine |
| 01/19/2005 | CN1565588A Neck and loin applied bony spur plaster |
| 01/19/2005 | CN1565583A Chinese drugs compositions for treating diabetes and its complications |
| 01/19/2005 | CN1565581A Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum |
| 01/19/2005 | CN1565566A Medicine for relieving stagnation by promoting qi circulation and removing pain |
| 01/19/2005 | CN1565562A Medicine capable of promoting blood circulation to arrest pain |
| 01/19/2005 | CN1565560A Anti-inflammation and antipyretic medicine |
| 01/19/2005 | CN1565557A Chinese traditional medicine for treating arthralgia syndrome and its preparation |
| 01/19/2005 | CN1565553A Dysmenorrhea treating Chinese traditional medicine |
| 01/19/2005 | CN1565545A Rheumatoid disease treating medicine |
| 01/19/2005 | CN1565541A Osteodynia alleviating and wind dispelling liniment |
| 01/19/2005 | CN1565538A Ache removing medicinal capsule for rheumatoid arthritis and its manufacturing technique |
| 01/19/2005 | CN1565526A Orthopaedics used externally applied plaster with integrated functions of stopping pain, eliminating swelling and promoting bone fracture recovery |
| 01/19/2005 | CN1565508A Trauma treating medicinal liquor |
| 01/19/2005 | CN1565503A Novel |
| 01/19/2005 | CN1565499A Chinese traditional medicine for treating traumatic injury |
| 01/19/2005 | CN1565496A Gynecological inflammation treating powder and its preparation |
| 01/19/2005 | CN1565487A Gynecopathy treating pills and its preparation method |
| 01/19/2005 | CN1565476A Iodine ion injection liquid |
| 01/19/2005 | CN1565474A Biochemical nucleic acid fulvic acid oral liquid production method |
| 01/19/2005 | CN1565469A Cornel extract oral medicine compositions low irritative to gastrointestinal tract and its preparation |
| 01/19/2005 | CN1565453A 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect |
| 01/19/2005 | CN1565438A Use of 5-hydroxymethyl furfural in preparation of drug for nerve system |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/19/2005 | CN1185232C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185226C Intermediate for preparing benzothiophene amide derivate |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185212C Salicylamide derivatives |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185014C Biodegradation type introducing agent of hardly water-soluble steroid, nonsteroid anti-inflammatory medicine, and its prepn. method |
| 01/19/2005 | CN1185009C Eye preparation |
| 01/19/2005 | CN1185005C Medicine for treating inflammation and its preparation method |
| 01/19/2005 | CN1184981C Antalgic liniment |
| 01/18/2005 | US6845245 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 01/18/2005 | US6844457 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/18/2005 | US6844359 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis |
| 01/18/2005 | US6844345 Piperazine derivatives |
| 01/18/2005 | US6844341 Cell cycle kinase inhibitors; such as 2-(4-(N-(2-methoxy-ethyl)-sulphamoyl)anilino)-4-(imidazo(1,2b)pyridazin-3 -yl)-pyrimidine |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/18/2005 | US6844332 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844331 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844330 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-NOR-vitamin D3 and their uses |
| 01/18/2005 | US6844328 Antiproliferative activity; low systemic toxicity; psoriasis, tumors, rheumatoid arthritis, intestinal inflammation |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/18/2005 | US6844131 Positive-working photoimageable bottom antireflective coating |
| 01/18/2005 | US6844012 Suppressing cytokine secretion with such as sodium selenite |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | CA2269638C Ice inhibiting peptides |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/16/2005 | CA2465681A1 The use of conjugated linoleic acid or derivative thereof for the treatment of the common cold |
| 01/13/2005 | WO2005003347A2 Dna-based aptamers for human cathepsin g |
| 01/13/2005 | WO2005003177A2 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 01/13/2005 | WO2005003145A1 Shanzhuyu extract and uses thereof |
| 01/13/2005 | WO2005003127A1 Bicyclic heteroaromatic derivatives as modulators of cxcr3 function |
| 01/13/2005 | WO2005003118A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 01/13/2005 | WO2005002611A1 Formulations for the treatment of arhritis conditions |
| 01/13/2005 | WO2005002590A1 Agent inducing increase in bone mass |
| 01/13/2005 | WO2005002572A2 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 01/13/2005 | WO2005002558A1 Preventive and/or therapeutic agent for inflammatory bowel disease |
| 01/13/2005 | WO2005002525A2 Cox-2 and faah inhibitors |
| 01/13/2005 | WO2004100986A3 Pharmaceutical use of an adam 10 inhibitory substance |
| 01/13/2005 | WO2004082567A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 01/13/2005 | WO2004078744A3 Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
| 01/13/2005 | WO2004072047A8 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | US20050010052 P2X7 receptor (a ligand-gated ion channel) antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases; osteoarthritis |
| 01/13/2005 | US20050010050 Antiinflammatory agents; antiarthritic agents; anticancer agents; analgesics |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009874 Tetrahydropyridin or piperidino heterocyclic derivatives |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009845 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009808 Azabicyclo compound matrix metalloprotease inibitor and skin preparation |
| 01/13/2005 | US20050009795 Mixtures or organic compounds for the treatment of airway diseases |
| 01/13/2005 | US20050009791 Especially lysine, arginine, histidine, omithine and diaminobutyric acid; improved solubility for parenteral administration |
| 01/13/2005 | US20050009778 Method for treating retinal degeneration with purinergic receptor agonists |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050009747 High purity lipopeptides |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050008688 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 01/13/2005 | US20050008655 Useful as barrier applied to skin; chemical and radiation resistance; skin disorders; autoimmune diseases; antitumor agents; topical applying |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | US20050008568 Complex containing dithiocarbamate compound |
| 01/13/2005 | CA2532066A1 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 01/13/2005 | CA2531061A1 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | CA2530816A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronic inflammatory diseases |
| 01/13/2005 | CA2530808A1 Cox-2 and faah inhibitors |
| 01/13/2005 | CA2530494A1 Formulations for the treatment of arthritis conditions |
| 01/13/2005 | CA2529558A1 Agent inducing increase in bone mass |